MarketPeel
Pricing
…
President and CEO
Stanley C. Erck
Sun, Mar 8, 2020
Mar 8
exercised or converted securities in
NVAX
6,072
shares @ $0.00
Decreased holdings by
-100.00%
Net across this filing:
+24.90%
(+4,080 shares)
NVAX
NOVAVAX INC
Health Care
Biotechnology
1D
-3.91%
1W
+6.44%
1M
+15.15%
3M
-17.88%
6M
—
1Y
—
Recent insider activity at NVAX
Dec 31
James F. Young
Sold
$43.20k
Dec 24
James F. Young
Sold
$39.01k
Dec 13
Rachel K. King
Sold
$37.44k
Jun 21
James F. Young
Sold
$105.67k
Jun 18
James F. Young
Sold
$87.07k
Jun 18
James F. Young
Sold
$15.81k
Jun 17
Filip Dubovsky
Sold
$180.75k
Jun 17
Filip Dubovsky
Sold
$20.41k
Full NVAX profile →
Stanley C. Erck’s trading history →
FREE · DAILY · 6 AM ET
The morning brief, before the bell.
One short email. Insider buys, congressional trades, and plain-English analysis.
Subscribe
Feedback